GSK’s Chief Executive Hoping To Hold Off Calls For The Company To Break Up

    GlaxoSmithKline’s Chief Executive, Sir Andrew Witty, won’t easily silence the calls for a breakup of the pharmaceuticals giant – but the company’s decent finish to 2015 should buy him some time to move at his own pace. Read the full

    The full content of this article is restricted to NamNews Subscribers. If you are an existing user, please log in below. Forgotten your password? Any problems logging in, contact us

    Existing Users Log In
     Remember Me